CLINICAL_TRIALS
trial_result
· 2022-03-07
Clinical Trial Update: A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea
Summary
Post-marketing surveillance study on NesinaAct tablet use in Korean participants with Type 2 Diabetes Mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2022-03-07